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Congenital Hypothyroidism is the commonest preventable
cause of intellectual disability. Newborn screening with
early identification and treatment has resulted in near nor-
malisation of long term intellectual outcomes in the
affected children. However, a number of issues still remain
to be clarified. Firstly, while there has been a marked
improvement in intellectual outcomes many studies have
shown persistent cognitive deficits compared to control
populations. It has generally been considered that this def-
icit reflected antenatal reductions in fetal thyroxine expo-
sure and was unavoidable. However, variables such
treatment delay and low thyroxine doses when initiating
may also contribute. There is now data to suggest early
diagnosis and treatment with high dose thyroxine and
frequent blood testing can result in completely normal
cognitive outcome when compared to healthy siblings.
Treatment paradigms will be discussed that normalise
cognition, with suggestions of management regimes that
can be used in areas of the Asia-Pacific region where thyr-
oid function testing is more difficult.
The frequency of congenital hypothyroidism is increasing
world-wide. This is in part related to changes in the new-
born cut-offs which have reduced in many countries.
Other reasons have also been suggested and the ethnic
composition of the countries seems very relevant. Asian
and Pacific peoples appear to have a much higher inci-
dence of dyshormonogenesis and rates are of congenital
hypothyroidism are climbing more rapidly in countries
where the proportion of these ethnicities is increasing.
There also remains ongoing concern about the appro-
priate cut-offs for notification of hypothyroidism. Indeed
there has been an international trend for lower cut-offs
resulting in many children being diagnosed with sub-
clinical hypothyroidism. The relevance of diagnosing
these children remains unclear with most likely being
normal. I will discuss the use of different cut-offs and
how these can affect the diagnosis and management of
congenital hypothyroidism, as well as what should be
the appropriate cut-offs in less affluent countries and
the common reasons for missed diagnoses.
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